Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 7/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ABL1 | P00519 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.35 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.35 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.35 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.33 |
| ▸ | LPL | P06858 | 1/20 | 0.33 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13799820 | 1.00 | CNR2 (0.38) | CNR2KDM4EABL1LMNALIPG | |
| SCHEMBL16433645 | 0.94 | KDM4E (0.39) | CNR2KDM4EABL1LMNATSHR | |
| SCHEMBL12962015 | 0.92 | CNR2 (0.40) | CNR2KDM4EABL1LMNALIPG | |
| SCHEMBL13799819 | 0.84 | LIPG (0.48) | KDM4EABL1LMNALIPGHRH3 | |
| SCHEMBL10107285 | 0.84 | LIPG (0.48) | KDM4EABL1LMNALIPGHRH3 | |
| SCHEMBL10107306 | 0.83 | KDM4E (0.43) | KDM4EABL1LMNALIPGHRH3 | |
| SCHEMBL13799821 | 0.83 | KDM4E (0.43) | KDM4EABL1LMNALIPGHRH3 | |
| SCHEMBL13813306 | 0.82 | CNR2 (0.40) | CNR2KDM4EABL1LMNALIPG | |
| SCHEMBL10107254 | 0.78 | KDM4E (0.41) | KDM4EABL1LMNALIPGHRH3 | |
| SCHEMBL13799813 | 0.78 | KDM4E (0.41) | KDM4EABL1LMNALIPGHRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE45364-E1 | Cyclic amine compound and pest control agent | NIPPON SODA CO., LTD. (JP) | 2015-02-03 | — | — | US | disclosed |
| US-8101768-B2 | Cyclic amine compound and pest control agent | NIPPON SODA CO., LTD. (JP) | 2012-01-24 | — | — | US | disclosed |
| US-8101768-B2 | Cyclic amine compound and pest control agent | NIPPON SODA CO., LTD. (JP) | 2012-01-24 | — | — | US | disclosed |
| US-7868178-B2 | Cyclic amine compound and pest control agent | NIPPON SODA CO., LTD. (JP) | 2011-01-11 | — | — | US | disclosed |
| US-7485727-B2 | Cyclic amine compound and pest control agent | NIPPON SODA CO., LTD. (JP) | 2009-02-03 | — | — | US | disclosed |
| US-7485727-B2 | Cyclic amine compound and pest control agent | NIPPON SODA CO., LTD. (JP) | 2009-02-03 | — | — | US | disclosed |
| US-20080319003-A1 | CYCLIC AMINE COMPOUND AND PEST CONTROL AGENT | NIPPON SODA CO., LTD. (JP) | 2008-12-25 | — | — | US | disclosed |
| US-20080045569-A1 | Cyclic Amine Compound and Pest Control Agent | NIPPON SODA CO., LTD. (JP) | 2008-02-21 | — | — | US | disclosed |
| US-20080045569-A1 | Cyclic Amine Compound and Pest Control Agent | NIPPON SODA CO., LTD. (JP) | 2008-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080045569-A1 | Cyclic Amine Compound and Pest Control Agent | H1-0, H1-2, H1-4 | CNR2 1207/4885KDM4E 373/4885ABL1 876/4885 |
| US-20080319003-A1 | CYCLIC AMINE COMPOUND AND PEST CONTROL AGENT | H1-0, H1-2, H1-4 | CNR2 1312/4885KDM4E 339/4885ABL1 873/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.